Reminder: November 27, 2024 Insulin Litigation Deadline

As announced in our August 20, 2024 E-Blast and August School Law Notes, entities nationwide are joining a lawsuit against insulin manufacturers, pharmacy benefit managers, and others accused of artificially inflating insulin prices at the expense of employers and health plan entities, including insurance pools. The defendants include, among others, Eli Lilly and Company, Novo Nordisk Inc., and Sanofi-Aventis US LLC. Any self-insured employer, any employer that contributed to employee medical benefit plan costs or other health care costs, and any insurance pool may join the lawsuit.

To join the litigation, your board must approve a resolution and contract. To obtain those documents, please email pmatusiak@thrunlaw.com. Signed resolutions - and signed and initialed contracts - must be returned by November 27, 2024 to that same email address. If you would like more information about the litigation, please contact Piotr Matusiak at pmatusiak@thrunlaw.com or call (517) 374-8824.